share_log

EyePoint Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Hassan Fred

SEC ·  Sep 6 04:08
Summary by Futu AI
EyePoint Pharmaceuticals, Inc. (EYPT) has reported an initial statement of beneficial ownership of securities filed by director and 10% owner, Fred Hassan. The SEC Form 3, filed on September 3, 2024, indicates that Hassan does not beneficially own any non-derivative or derivative securities of the company. The form, signed by attorney-in-fact Ron Honig on September 5, 2024, is a routine disclosure required by the United States Securities and Exchange Commission for individuals in Hassan's position.
EyePoint Pharmaceuticals, Inc. (EYPT) has reported an initial statement of beneficial ownership of securities filed by director and 10% owner, Fred Hassan. The SEC Form 3, filed on September 3, 2024, indicates that Hassan does not beneficially own any non-derivative or derivative securities of the company. The form, signed by attorney-in-fact Ron Honig on September 5, 2024, is a routine disclosure required by the United States Securities and Exchange Commission for individuals in Hassan's position.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated